en
Scientific article
English

The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria

Published inBritish journal of dermatology, vol. 148, no. 3, p. 604-606
Publication date2003
Keywords
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
  • Chronic Disease
  • Cyclooxygenase Inhibitors/*therapeutic use
  • Female
  • Histamine Release/drug effects
  • Humans
  • Lactones/*therapeutic use
  • Male
  • Middle Aged
  • Sulfones
  • Urticaria/*drug therapy
Affiliation Not a UNIGE publication
Citation (ISO format)
BOEHNCKE, Wolf-Henning et al. The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria. In: British journal of dermatology, 2003, vol. 148, n° 3, p. 604–606. doi: 10.1046/j.1365-2133.2003.05209_12.x
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0007-0963
486views
0downloads

Technical informations

Creation09/20/2013 4:48:32 PM
First validation09/20/2013 4:48:32 PM
Update time03/14/2023 8:25:28 PM
Status update03/14/2023 8:25:28 PM
Last indexation02/12/2024 8:32:27 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack